Emcure Pharmaceuticals Ltd. EMCURE.NS
Finances
| Revenue |
| Net income |
| Income before tax |
| Income before tax ratio |
| EBITDA |
| Net income ratio |
| Ratio EBITDA |
| Gross profit ratio |
| Weighted average shs out dil |
| Weighted average shs out |
| EPS diluted |
| Earnings per share |
| Gross profit |
| Income tax expense |
| Cost of revenue |
| General and administrative expenses |
| Selling and marketing expenses |
| Other expenses |
| Operating expenses |
| Cost and expenses |
| Research and development expenses |
| Selling general and administrative expenses |
| Interest income |
| Interest expense |
| Depreciation and amortization |
| Operating income |
| Operating income ratio |
| Total other income expenses net |
| Net debt |
| Total investments |
| Total debt |
| Accumulated other comprehensive income loss |
| Retained earnings |
| Common stock |
| Total equity |
| Other non current liabilities |
| Long term debt |
| Total non current liabilities |
| Other current liabilities |
| Deferred revenue |
| Short term debt |
| Total current liabilities |
| Total liabilities |
| Other non current assets |
| Long term investments |
| Intangible assets |
| GoodWill |
| Goodwill and intangible assets |
| Property plant equipment net |
| Total non current assets |
| Other current assets |
| Short term investments |
| cash and cash equivalents |
| Cash and short term investments |
| Total current assets |
| Inventory |
| Net receivables |
| Tax assets |
| Other assets |
| Account payables |
| Tax payables |
| Deferred revenue non current |
| Minority interest |
| Capital lease obligations |
| Preferred stock |
| Other total stockholders equity |
| Deferred tax liabilities non current |
| Other liabilities |
| Total assets |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| Revenue | 22.698 B 8.06 % | 21.005 B 3.55 % | 20.285 B 3.36 % | 19.626 B -1.97 % | 20.020 B |
| Net income | 2.435 B 17.64 % | 2.070 B 9.52 % | 1.890 B 22.92 % | 1.537 B -20.99 % | 1.946 B |
| Income before tax | 3.414 B 17.42 % | 2.908 B 11.57 % | 2.606 B 13.35 % | 2.299 B -15.91 % | 2.734 B |
| Income before tax ratio | 0.15 8.67 % | 0.14 7.74 % | 0.13 9.67 % | 0.12 -14.22 % | 0.14 |
| EBITDA | 4.786 B 14.78 % | 4.170 B 15.60 % | 3.607 B 0.61 % | 3.585 B -13.93 % | 4.165 B |
| Net income ratio | 0.11 8.87 % | 0.10 5.77 % | 0.09 18.93 % | 0.08 -19.41 % | 0.10 |
| Ratio EBITDA | 0.21 6.22 % | 0.20 11.64 % | 0.18 -2.66 % | 0.18 -12.20 % | 0.21 |
| Gross profit ratio | 0.61 -1.63 % | 0.62 30.52 % | 0.47 -21.22 % | 0.60 -0.80 % | 0.61 |
| Weighted average shs out dil | 189.466 M -0.03 % | 189.517 M | 0.000 -100.00 % | 189.313 M 0.99 % | 187.449 M |
| Weighted average shs out | 189.466 M -0.03 % | 189.517 M | 0.000 -100.00 % | 189.313 M 0.99 % | 187.449 M |
| EPS diluted | 12.85 17.67 % | 10.92 | 0.00 -100.00 % | 8.12 -21.77 % | 10.38 |
| Earnings per share | 12.85 17.67 % | 10.92 | 0.00 -100.00 % | 8.12 -21.77 % | 10.38 |
| Gross profit | 13.803 B 6.30 % | 12.985 B 35.16 % | 9.607 B -18.57 % | 11.799 B -2.75 % | 12.133 B |
| Income tax expense | 900.470 M 18.54 % | 759.650 M 19.86 % | 633.760 M -14.16 % | 738.280 M 2.74 % | 718.610 M |
| Cost of revenue | 8.895 B 10.91 % | 8.020 B -24.89 % | 10.678 B 36.42 % | 7.827 B -0.75 % | 7.887 B |
| General and administrative expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Selling and marketing expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Other expenses | 10.458 B 5.20 % | 9.941 B 48.89 % | 6.677 B -27.03 % | 9.150 B -1.55 % | 9.293 B |
| Operating expenses | 10.458 B 5.20 % | 9.941 B 48.89 % | 6.677 B -27.03 % | 9.150 B -1.55 % | 9.293 B |
| Cost and expenses | 19.353 B 7.75 % | 17.961 B 3.50 % | 17.354 B 2.22 % | 16.977 B -1.18 % | 17.180 B |
| Research and development expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Selling general and administrative expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Interest income | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |
| Interest expense | 325.420 M 21.63 % | 267.550 M 723.48 % | 32.490 M -89.78 % | 317.780 M -31.25 % | 462.210 M |
| Depreciation and amortization | 1.046 B 5.22 % | 994.560 M 2.70 % | 968.370 M 0.03 % | 968.060 M -0.09 % | 968.960 M |
| Operating income | 3.345 B 9.87 % | 3.044 B 3.87 % | 2.931 B 10.63 % | 2.649 B -6.71 % | 2.840 B |
| Operating income ratio | 0.15 1.68 % | 0.14 0.31 % | 0.14 7.03 % | 0.13 -4.83 % | 0.14 |
| Total other income expenses net | 69.350 M 150.71 % | -136.760 M 57.89 % | -324.740 M 7.26 % | -350.170 M -231.38 % | -105.670 M |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 2025-09-30 | 2025-03-31 | 2024-09-30 | 2024-03-31 | |
|---|---|---|---|---|
| Net debt | 11.870 B 31.75 % | 9.009 B -12.25 % | 10.267 B -53.88 % | 22.260 B |
| Total investments | 596.250 M 184.05 % | 209.910 M -67.74 % | 650.780 M 248.12 % | 186.940 M |
| Total debt | 16.592 B 62.23 % | 10.227 B -13.97 % | 11.888 B -49.09 % | 23.350 B |
| Accumulated other comprehensive income loss | 0.000 | 0.000 | 0.000 | 0.000 |
| Retained earnings | 0.000 -100.00 % | 33.129 B | 0.000 -100.00 % | 26.340 B |
| Common stock | 1.896 B 0.04 % | 1.895 B 0.20 % | 1.891 B 4.39 % | 1.812 B |
| Total equity | 48.840 B 5.22 % | 46.416 B 7.86 % | 43.033 B 37.85 % | 31.218 B |
| Other non current liabilities | 1.162 B -65.93 % | 3.411 B -4.39 % | 3.568 B 5.59 % | 3.379 B |
| Long term debt | 5.951 B 33.05 % | 4.473 B -10.61 % | 5.003 B -49.07 % | 9.823 B |
| Total non current liabilities | 8.225 B -10.88 % | 9.229 B -6.69 % | 9.891 B -32.90 % | 14.739 B |
| Other current liabilities | 7.895 B 57.61 % | 5.009 B -8.61 % | 5.481 B 10.71 % | 4.950 B |
| Deferred revenue | 0.000 | 0.000 | 0.000 | 0.000 |
| Short term debt | 10.641 B 84.91 % | 5.755 B -16.41 % | 6.885 B -49.10 % | 13.526 B |
| Total current liabilities | 36.860 B 38.14 % | 26.683 B -5.78 % | 28.321 B -11.79 % | 32.105 B |
| Total liabilities | 45.085 B 25.54 % | 35.912 B -6.02 % | 38.212 B -18.43 % | 46.844 B |
| Other non current assets | 2.124 B 21.50 % | 1.748 B -2.06 % | 1.785 B 17.63 % | 1.517 B |
| Long term investments | 0.000 | 0.000 | 0.000 | 0.000 |
| Intangible assets | 6.168 B 6.49 % | 5.792 B -6.66 % | 6.206 B 22.21 % | 5.078 B |
| GoodWill | 3.948 B 7.36 % | 3.678 B -3.80 % | 3.823 B 0.95 % | 3.787 B |
| Goodwill and intangible assets | 10.117 B 6.83 % | 9.470 B -5.57 % | 10.029 B 13.13 % | 8.865 B |
| Property plant equipment net | 24.398 B -0.17 % | 24.440 B 2.66 % | 23.807 B -1.27 % | 24.113 B |
| Total non current assets | 37.870 B 3.00 % | 36.769 B 0.22 % | 36.686 B 3.45 % | 35.462 B |
| Other current assets | 3.996 B 7.77 % | 3.707 B 8.10 % | 3.430 B -13.92 % | 3.985 B |
| Short term investments | 1.293 B 70.02 % | 760.430 M -55.19 % | 1.697 B -41.32 % | 2.892 B |
| cash and cash equivalents | 4.723 B 287.65 % | 1.218 B -24.84 % | 1.621 B 48.76 % | 1.090 B |
| Cash and short term investments | 6.015 B 204.01 % | 1.979 B -40.37 % | 3.318 B -16.67 % | 3.982 B |
| Total current assets | 56.055 B 23.04 % | 45.559 B 2.24 % | 44.558 B 4.60 % | 42.599 B |
| Inventory | 23.046 B 19.30 % | 19.318 B 10.29 % | 17.516 B 14.85 % | 15.251 B |
| Net receivables | 22.999 B 11.89 % | 20.554 B 1.28 % | 20.295 B 4.71 % | 19.382 B |
| Tax assets | 1.231 B 10.93 % | 1.110 B 4.09 % | 1.066 B 10.16 % | 967.960 M |
| Other assets | 0.000 | 0.000 | 0.000 | 0.000 |
| Account payables | 17.254 B 16.62 % | 14.796 B -1.82 % | 15.069 B 15.09 % | 13.094 B |
| Tax payables | 1.070 B -4.72 % | 1.123 B 26.70 % | 886.400 M 65.85 % | 534.450 M |
| Deferred revenue non current | 0.000 -100.00 % | 144.930 M | 0.000 -100.00 % | 162.660 M |
| Minority interest | 1.415 B -27.60 % | 1.954 B 5.63 % | 1.850 B 9.13 % | 1.695 B |
| Capital lease obligations | 3.152 B 8.28 % | 2.910 B 17.86 % | 2.469 B -0.29 % | 2.477 B |
| Preferred stock | 0.000 | 0.000 | 0.000 | 0.000 |
| Other total stockholders equity | 45.530 B 382.43 % | 9.438 B -75.98 % | 39.293 B 2 765.51 % | 1.371 B |
| Deferred tax liabilities non current | 1.112 B -7.39 % | 1.200 B -9.02 % | 1.319 B -3.99 % | 1.374 B |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 |
| Total assets | 93.925 B 14.09 % | 82.327 B 1.33 % | 81.245 B 4.08 % | 78.062 B |
| 2025-09-30 | 2025-03-31 | 2024-09-30 | 2024-03-31 |
| Deferred income tax |
| Stock based compensation |
| Change in working capital |
| Accounts receivables |
| Inventory |
| Accounts payables |
| Other working capital |
| Other non cash items |
| Net cash provided by operating activities |
| Investments in property plant and equipment |
| Acquisitions net |
| Purchases of investments |
| Sales maturities of investments |
| Other investing activites |
| Net cash used for investing activites |
| Debt repayment |
| Common stock issued |
| Common stock repurchased |
| Dividends paid |
| Other financing activites |
| Net cash used provided by financing activities |
| Effect of forex changes on cash |
| Net change in cash |
| Cash at beginning of period |
| Cash at end of period |
| Operating cash flow |
| Capital expenditure |
| Free CashFlow |
| Date | Form 10K |
|---|